A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage damaged p53. This essential cancer inhibitor protein is frequently inactivated in several kinds of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research